The Healing Company Inc.
HLCO
$0.0001
-$0.0349-99.71%
| Weiss Ratings | HLCO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | HLCO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Weak | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | HLCO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -0.50 | |||
| Price History | HLCO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -99.71% | |||
| 30-Day Total Return | -99.90% | |||
| 60-Day Total Return | -99.98% | |||
| 90-Day Total Return | -99.99% | |||
| Year to Date Total Return | -99.99% | |||
| 1-Year Total Return | -100.00% | |||
| 2-Year Total Return | -100.00% | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -100.00% | |||
| 52-Week Low % Change | 0.00% | |||
| Price | HLCO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $5.10 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | May 16, 2024 | |||
| 52-Week High Price (Date) | Jul 05, 2023 | |||
| Valuation | HLCO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 6.01K | |||
| Enterprise Value | 3.72M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.33 | |||
| Earnings Per Share Growth | -1.30% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.00 | |||
| Price/Book (Q) | 0.00 | |||
| Enterprise Value/Revenue (TTM) | 0.31 | |||
| Price | $0.00 | |||
| Enterprise Value/EBITDA (TTM) | -0.22 | |||
| Enterprise Value/EBIT | -0.22 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | HLCO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 57.39M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | HLCO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 866 241 0670 | |||
| Address | 135 West 50th Street New York, NY 10020 | |||
| Website | www.healingcompany.com | |||
| Country | United States | |||
| Year Founded | 2008 | |||
| Profitability | HLCO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -144.15% | |||
| Profit Margin | -154.43% | |||
| Management Effectiveness | HLCO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -127.24% | |||
| Return on Equity | -- | |||
| Income Statement | HLCO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 11.99M | |||
| Total Revenue (TTM) | 11.99M | |||
| Revenue Per Share | $0.21 | |||
| Gross Profit (TTM) | 3.91M | |||
| EBITDA (TTM) | -16.97M | |||
| EBIT (TTM) | -17.28M | |||
| Net Income (TTM) | -18.51M | |||
| Net Income Avl. to Common (TTM) | -18.51M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | 38.45% | |||
| EPS Diluted (TTM) | -0.33 | |||
| EPS Diluted Growth (Q YOY) | 52.67% | |||
| Balance Sheet | HLCO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 1.42M | |||
| Cash Per Share (Q) | $0.02 | |||
| Total Current Assets (Q) | 6.85M | |||
| Total Preferred Equity (Q) | 0.00 | |||
| Total Equity (Q) | -1.86M | |||
| Current Ratio (Q) | 0.491 | |||
| Book Value Per Share (Q) | -$0.03 | |||
| Total Assets (Q) | 12.07M | |||
| Total Current Liabilities (Q) | 13.94M | |||
| Total Debt (Q) | 5.13M | |||
| Total Liabilities (Q) | 13.94M | |||
| Total Common Equity (Q) | -1.86M | |||
| Cash Flow | HLCO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -2.34M | |||
| Cash from Financing (TTM) | 10.02M | |||
| Net Change in Cash (TTM) | -1.29M | |||
| Levered Free Cash Flow (TTM) | -2.27M | |||
| Cash from Operations (TTM) | -8.91M | |||
